Prediagnostic body mass index and pancreatic cancer survival. - Wikidata - wikimedia - TriplyDB

Prediagnostic body mass index and pancreatic cancer survival.

Prediagnostic body mass index and pancreatic cancer survival.

http://www.wikidata.org/entity/Q34656804

about

Oncogenic role of leptin and Notch interleukin-1 leptin crosstalk outcome in cancer Pancreatic Cancer Metabolism: Breaking It Down to Build It Back Up Targeting p110gamma in gastrointestinal cancers: attack on multiple fronts Obesity and cancer pathogenesis.Obesity-Induced Inflammation and Desmoplasia Promote Pancreatic Cancer Progression and Resistance to Chemotherapy.Leptin-Notch signaling axis is involved in pancreatic cancer progression Dietary energy balance modulates ovarian cancer progression and metastasis.Survival in overweight patients with advanced pancreatic carcinoma: a multicentre cohort study.Obesity and head and neck cancer risk and survival by human papillomavirus serology.Metformin prevents aggressive ovarian cancer growth driven by high-energy diet: similarity with calorie restriction.Severe obesity prior to diagnosis limits survival in colorectal cancer patients evaluated at a large cancer centre Influence of Body Mass Index and Albumin on Perioperative Morbidity and Clinical Outcomes in Resected Pancreatic Adenocarcinoma.Effect of Body Mass Index on Overall Survival of Pancreatic Cancer: A Meta-Analysis An Attempt to Evaluate Selected Aspects of "Bone-Fat Axis" Function in Healthy Individuals and Patients With Pancreatic Cancer Impacts of new-onset and long-term diabetes on clinical outcome of pancreatic cancer.Evaluation of Body Mass Index and Survival of Nasopharyngeal Carcinoma by Propensity-Matched Analysis: An Observational Case-Control Study.Circulating Metabolites and Survival Among Patients With Pancreatic Cancer Premorbid Obesity and Mortality in Patients With Pancreatic Cancer: A Systematic Review and Meta-analysis.Prediagnostic Plasma 25-Hydroxyvitamin D and Pancreatic Cancer Survival A pilot study of radiologic measures of abdominal adiposity: weighty contributors to early pancreatic carcinogenesis worth evaluating?TTD consensus document on the diagnosis and management of exocrine pancreatic cancer.Prognostic factors related with survival in patients with pancreatic adenocarcinoma Predicting early mortality in resectable pancreatic adenocarcinoma: A cohort study.Cigarette Smoking and Pancreatic Cancer Survival.Critical role for arginase 2 in obesity-associated pancreatic cancer.A high BMI is a risk factor in younger patients with de novo acute myelogenous leukemia.Positive Effect of Higher Adult Body Mass Index on Overall Survival of Digestive System Cancers Except Pancreatic Cancer: A Systematic Review and Meta-Analysis.Body mass index does not affect the survival of pancreatic cancer patients.Use of Angiotensin System Inhibitors Is Associated with Immune Activation and Longer Survival in Nonmetastatic Pancreatic Ductal Adenocarcinoma.Adipocytes sustain pancreatic cancer progression through a non-canonical WNT paracrine network inducing ROR2 nuclear shuttling.Obesity and Pancreatic Cancer.Inflammatory, insulin resistance metabolic markers and pancreatic cancer: quo vadis? [corrected].Plasma inflammatory cytokines and survival of pancreatic cancer patients.The Plausibility of Obesity Paradox in Cancer-Point.Visceral and subcutaneous fat as new independent predictive factors of survival in locally advanced gastric carcinoma patients treated with neo-adjuvant chemotherapy.Impact of sarcopenia in borderline resectable and locally advanced pancreatic cancer patients receiving stereotactic body radiation therapy.Cachexia, and not obesity, prior to pancreatic cancer diagnosis worsens survival and is negated by chemotherapy.Altered exocrine function can drive adipose wasting in early pancreatic cancer

P2860

Q26750563-2626FEC1-D6F1-4850-88B3-06FBDCC09CE7 Q26780372-00286BFD-0755-435B-A4D4-EE2D3D427273 Q26823575-B57645E9-453B-464C-ADA2-897A9F30F4DC Q30361298-0BD508C6-6DC8-48DC-8081-F7844D9B802C Q30388746-6A6E58C0-C395-4641-A4C6-2FD25A8511E7 Q30396675-52CBAA29-2090-4A27-8A0F-B3DDECA3D45F Q34227594-B41FA962-28D2-4B0B-8145-52A43CF14BC9 Q34566049-6F6038B1-B20E-448D-9E31-CB459A6D10D5 Q34998853-BD05D00B-5BC1-431C-B799-96975F338774 Q35793665-4DDFB992-38E5-4140-86ED-103225AFFE74 Q35872088-3A5D15B9-D3C8-41B5-9C30-DAEA60E191CA Q35970523-75A78195-0836-45E5-940C-DBF7FF2F3712 Q35983454-89393522-F9E6-4E83-ACF8-D1CD1C9C8A40 Q36195090-88D901D2-3A02-4308-8284-0133CC0449EF Q36309449-7003E210-3BF6-481A-8C4D-FCB11D75080F Q36478060-E71B54C4-C922-4004-85CC-7B4080481B52 Q36848069-23B741E9-015C-49DF-B51D-5EF7F21C864F Q37033546-584576C8-334A-4BFD-843F-3B5A0B848FCE Q37234780-5C0B26F6-17E6-4101-8212-50D80D788D05 Q37720426-BFE24564-81DE-431D-A8C9-73035C6ECAAF Q38204280-BB6AAA94-61CB-4A30-B3BB-C542670B9387 Q38242807-B356266F-11F2-415D-BCD9-05E0E727E75D Q39040017-A8AAD01A-9FE4-49FA-ADD7-B1ABD098438D Q40266936-3E515AD2-42B5-436A-A5BF-9385F767B7FC Q41388458-ADBE70C0-4A17-4946-9A26-60AB7EAA2126 Q41479185-5E981722-39BC-4D32-91F6-CF468E661012 Q41691021-A3797CAB-D47C-4501-9F30-9DEF4A4F3A23 Q42183979-46C8F3C6-AFC4-4D9E-A291-13E6272BF83F Q42776799-7BDC6D5C-A5D2-4FCA-AC9B-3A016B3CC798 Q48276795-F0F8E2D6-7861-4B6F-BAA5-A5DCB05426DC Q50856729-3DC49980-1F02-4B65-AA1A-105B00B0ABFA Q51217477-54623152-80B8-4402-837E-F4FE51C40D04 Q52565516-32FD53C8-1818-4FC6-9A50-D9D124343FA1 Q53073930-20DCB9F5-6812-4AA5-B0FA-34781464F1D3 Q53225944-92FFBFFB-DCF8-419E-AC4F-ADF1105BDD74 Q54965039-FD1D8BA2-A543-4ACB-ACB8-D9E96029097F Q55259105-81395EBE-AB47-466E-9E2B-D245036CFD25 Q59071091-D4968239-F8FC-423B-A97A-B090ABC2C35C

P2860

Prediagnostic body mass index and pancreatic cancer survival.

http://www.wikidata.org/entity/Q34656804

description

2013 nî lūn-bûn

@nan

2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Prediagnostic body mass index and pancreatic cancer survival.

@ast

Prediagnostic body mass index and pancreatic cancer survival.

@en

Prediagnostic body mass index and pancreatic cancer survival.

@nl

type

label

Prediagnostic body mass index and pancreatic cancer survival.

@ast

Prediagnostic body mass index and pancreatic cancer survival.

@en

Prediagnostic body mass index and pancreatic cancer survival.

@nl

prefLabel

Prediagnostic body mass index and pancreatic cancer survival.

@ast

Prediagnostic body mass index and pancreatic cancer survival.

@en

Prediagnostic body mass index and pancreatic cancer survival.

@nl

P1433

Q34656804-B040C715-20DE-41B4-A058-45F42F7C84B9

P1476

Q34656804-D35DE0C3-85E6-41E7-8030-4D915AA22956

P2093

Q34656804-50D9A258-0A2E-4EA4-A06C-D933E74D95BC

Q34656804-5E978251-3F2E-4267-B5B6-B44E18871688

Q34656804-750B449D-51E3-4DA8-A57F-E11A71A1F209

Q34656804-7B4D5E5C-418C-441B-98FE-13E50D45503B

Q34656804-BE4A0E27-BC82-498E-80DB-168BB525C428

Q34656804-BE748235-153B-426B-9948-4AF7F899C1F9

Q34656804-ED92CF38-72FE-4FDA-939C-BCEA8E65AEF5

Q34656804-F78EA0DC-C891-4EA7-83A7-750101AA71C7

P2860

Q34656804-01F12BE8-F9C1-4516-817A-A78A3B08FB99

Q34656804-085E6064-6DF2-41AA-9FE2-512566EEDCDA

Q34656804-0E2A5917-DE1D-434B-BCAE-D42FBB52FDC3

Q34656804-0F9FF986-5B73-4034-B030-82291E4506FC

Q34656804-2AA22D5A-BD8A-482B-BA21-3B18AB43DC9A

Q34656804-2E17ADC9-B498-4F45-B3E0-10592ECC92BE

Q34656804-31FDBA55-D7D0-4C97-B51E-189D4750CF0B

Q34656804-3EF1E9AE-4ED6-4569-A325-E71E98F5032F

Q34656804-41B5393D-A134-42BD-92E7-68E08B966663

Q34656804-42A87FD1-4613-4203-AC4E-B55F1B2C6B83

P304

Q34656804-A259D888-D148-4263-84B3-13608E5F75E9

P31

Q34656804-19CBDB37-FE0B-4524-885B-35A34C2C4512

P356

Q34656804-2C01DB0A-AF13-4854-A480-DEB5391BB2CA

P407

Q34656804-54360530-E3A6-42B1-8B29-21625594292B

P433

Q34656804-C6CCF31A-A2AE-41F6-A22C-DC363FA85029

P478

Q34656804-FEF5BDE7-5001-4FAF-982B-FAC6A49BD22E

P50

Q34656804-18F5F953-BA34-4692-A30C-6AFA21732459

Q34656804-DBAAAD3D-8D47-4F79-8B17-517123E75F1A

Q34656804-ECB5EEEC-1359-4B21-B2F4-A880C9000195

P577

Q34656804-1A34DE1C-9FCA-4316-98ED-45F910121C73

P698

Q34656804-59CA2BC8-4750-4DF3-90A0-E22EA07210D7

P932

Q34656804-B37C8946-12B3-450A-BB67-60F5CB71CD10

P356

JCO.2013.51.7532

P1433

Journal of Clinical Oncology

P1476

Prediagnostic body mass index and pancreatic cancer survival.

@en

P2093

Brian M Wolpin

http://www.w3.org/2001/XMLSchema#string

Chen Wu

http://www.w3.org/2001/XMLSchema#string

Chen Yuan

http://www.w3.org/2001/XMLSchema#string

Douglas A Rubinson

http://www.w3.org/2001/XMLSchema#string

Kimmie Ng

http://www.w3.org/2001/XMLSchema#string

Shuji Ogino

http://www.w3.org/2001/XMLSchema#string

Ying Bao

http://www.w3.org/2001/XMLSchema#string

Zhi Rong Qian

http://www.w3.org/2001/XMLSchema#string

P2860

Changes in Diet and Lifestyle and Long-Term Weight Gain in Women and Men

Distant metastasis occurs late during the genetic evolution of pancreatic cancer

New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer

Cancer statistics, 2013

Pancreatic cancer

Body mass index and risk, age of onset, and survival in patients with pancreatic cancer

Anthropometric measures, body mass index, and pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan).

Obesity adversely affects survival in pancreatic cancer patients.

Are risk factors associated with outcomes in pancreatic cancer?

Physical activity, obesity, height, and the risk of pancreatic cancer.

P304

4229-4234

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2013.51.7532

http://www.w3.org/2001/XMLSchema#string

P407

P433

33

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P50

Edward Giovannucci

Meir J Stampfer

P577

2013-10-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24145341

http://www.w3.org/2001/XMLSchema#string

P932

3821012

http://www.w3.org/2001/XMLSchema#string